New hope for advanced liver cancer: targeted radiation therapy trial launches
Disease control
Recruiting now
This study tests a drug called 177Lu-PSMA-617 in people with liver cancer that has spread and shows a specific marker (PSMA) on scans. The drug delivers radiation directly to cancer cells. The trial aims to see if this approach is safe and can help control the disease. About 10 a…
Phase: PHASE2 • Sponsor: Melissa Lumish • Aim: Disease control
Last updated May 19, 2026 11:48 UTC